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 In order to metabolize long-chain fatty acids in path-
ways of   -oxidation or the synthesis of complex lipids, they 
must fi rst be activated to acyl-CoAs by long-chain acyl-CoA 
synthetases (ACSLs). The fi ve mammalian ACSL isoforms 
each have a specifi c substrate preference, subcellular loca-
tion, and tissue distribution ( 1 ). In the heart, the ACSL1 
isoform predominates, such that with defi ciency, total 
ACSL specifi c activity and fatty acid oxidation decrease by 
more than 90% ( 2 ). Because ACSL activity is required for 
the incorporation of fatty acids into phospholipids, we 
asked whether the ACSL1 isoform is also required for the 
synthesis and remodeling of cardiac phospholipids, par-
ticularly cardiolipin (CL). 
 The mitochondrial phospholipid CL contributes to 
many aspects of mitochondrial function, including energy 
production through oxidative phosphorylation ( 3, 4 ), mi-
tochondrial fi ssion and fusion ( 5, 6 ), and cellular apopto-
sis ( 7 ). Tetralinoleoyl-CL is the predominant CL species in 
the mammalian heart ( 8 ), but the mechanism by which 
this species is formed is unclear. Because the enzymes of 
CL synthesis lack acyl-chain specifi city, nascent CL con-
tains a mixture of acyl chain lengths and degrees of un-
saturation ( 9 ). To obtain mature CL, most remodeling 
occurs within the mitochondria by sequentially removing 
each acyl chain to form monolyso-CL (MLCL) and then 
replacing the missing fatty acid with linoleate (18:2). Li-
noleate is added by transacylation from a donor phos-
pholipid ( 10 ) or by direct esterifi cation of a linoleoyl-CoA 
( 11, 12 ). 
 The transacylase tafazzin is believed to be responsible 
for cardiolipin remodeling. Mutations in tafazzin cause 
Barth syndrome, an X-linked cardiomyopathy charac-
terized by skeletal muscle weakness and heart failure in 
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water were added to separate phases. Radioactivity of the acyl-
CoAs in the aqueous phase was measured using a liquid scintilla-
tion counter. 
 Mitochondrial function studies 
 Mitochondrial function was measured in permeabilized myofi -
bers and in isolated mitochondria prepared from portions of the 
left ventricle and septum. After dissection, muscle samples were 
placed in ice-cold (4°C) Buffer X containing (in mM): 7.23 
K 2 EGTA, 2.77 CaK 2 EGTA, 20 imidazole, 20 taurine, 5.7 ATP, 
14.3 phosphocreatine, 6.56 MgCl 2 -6H 2 O, and 50 MES (pH 7.1, 
295 mOsm). Fibers were delicately separated in ice-cold Buffer X 
using fi ne forceps under a dissecting scope. Cardiac fi bers were 
then permeabilized in Buffer X with 50 µg/ml saponin for 30 min 
and then washed in ice-cold wash buffer Z (110 mM K-MES, 
35 mM KCl, 1 mM EGTA, 5 mM K 2 HPO 4 , 3 mM MgCl 2 ·6H 2 O, 
5 mg/ml BSA [pH 7.1, 295 mOsm]) to remove endogenous sub-
strates. To prevent Ca 2+ independent contraction of the permea-
bilized fi bers, 20   M blebbistatin was added to Buffer Z during 
wash and experiments. All mitochondrial O 2 consumption ( J O 2 ) 
measurements were performed at 30°C using the Oroboros O 2 K 
Oxygraph system (Oroboros Instruments). The H 2 O 2 and Ca 
2+ 
uptake measurements were performed in a spectrofl uorome-
ter (Photon Technology Instruments or Horiba Jobin Yvon), 
equipped with a thermo-jacketed cuvette chamber. All mitochon-
drial experiments were performed in Buffer Z plus 5 mg/ml BSA. 
Consumption of O 2 was measured with either 5 mM pyruvate 
plus 2 mM malate or 125 µM palmitoyl-carnitine plus 2 mM ma-
late. State 3 respiration was induced by adding ADP as indicated 
in the fi gure legends. 
 The rate of ATP production within the permeabilized myofi -
bers was continuously recorded alongside the O 2 consumption in 
real time by monitoring the increasing fl uorescence in the respi-
ration chamber coming from NADPH (340ex/460em) with a 
spectrofl uorometer as described ( 15 ). To maintain this reaction, 
2.5 U/ml of glucose-6-phosphate dehydrogenase (Roche), 
2.5 U/ml yeast hexokinase (Roche), 5 mM nicotinamide adenine 
dinucleotide phosphate (NADP + ) (Sigma-Aldrich), and 5 mM D-
glucose (Sigma-Aldrich) were added to the assay media. P1,P5-
Di(adenosine-5 ′ )pentaphosphate (Ap5A) (Sigma-Aldrich) was 
included in the respiration medium to inhibit adenylate kinase 
and to ensure that ATP production was solely due to mitochon-
drial oxidative phosphorylation. An absolute amount of ATP 
generated across a given time frame was then calculated using a 
standard curve of fi xed concentrations of ATP added to the satu-
rating amounts of hexokinase, glucose, G6PDH, and NADP + . Mi-
tochondrial H 2 O 2 emission was detected using Amplex UltraRed 
reagent (Invitrogen) in the presence of 1 U/ml HRP and 25 U/ml 
superoxide dismutase. The rate of H 2 O 2 produced from the 
mitochondrial electron transport system supported by 125 µM 
palmitoyl- L -carnitine, 5 mM glutamate, and 5 mM succinate oxi-
dation was determined in permeabilized fi bers with 100 µM ADP, 
5 mM glucose, and 1 U/ml hexokinase present to maintain the 
mitochondria in a permanent, submaximal phosphorylating 
state. 
 To isolate mitochondria, hearts were minced in 0.125 mg/ml 
trypsin in homogenization buffer (0.25 M sucrose, 10 mM 
HEPES, 1 mM EDTA [pH 7.4]). Soybean trypsin inhibitor 
(0.65 mg/ml) was added, and tissues were homogenized and cen-
trifuged at 500  g for 5 min to remove nuclei and unbroken cells. 
Mitochondria were isolated by centrifuging at 10,000  g for 15 min 
and washed twice with homogenization buffer. Calcium uptake 
was measured in Buffer Z using 1 µM Calcium Green 5-N with 
1 µM thapsigargin (Sigma-Aldrich) added to inhibit SERCA, a 
calcium transport ATPase. In separate experiments, the func-
tion of isolated mitochondria was assessed using a Seahorse 
childhood ( 13 ). Hearts with tafazzin loss-of-function mu-
tations contain low levels of tetralinoleoyl-CL and have a 
high ratio of MLCL to CL. Because tafazzin does not have 
a substrate preference for linoleate, it has been proposed 
that the linoleate enrichment of CL must be due to either 
an alteration in the physical shape of CL or by the action 
of an additional enzyme ( 10 ). 
 Here we show that ACSL1, which has a distinct prefer-
ence for linoleate, signifi cantly contributes to CL remodel-
ing. Because fatty acids must be converted to acyl-CoAs to 
be available for the initial steps in the synthesis of phos-
pholipids and to enter the mitochondrial matrix where CL 
remodeling occurs, we asked whether ACSL1 might be re-
sponsible for activating linoleate destined to be incorpo-
rated into CL. We found that hearts lacking ACSL1 are 
defi cient in tetralinoleoyl-CL but that normalizing the CL 
species cannot ameliorate the mitochondrial dysfunction 
present in these hearts. These fi ndings call into question 
the idea that the acyl-chains of CL are important for car-
diac and mitochondrial respiratory function. 
 MATERIALS AND METHODS 
 Animal care and diets 
 All protocols were approved by the Institutional Animal Care 
and Use Committee at University of North Carolina at Chapel 
Hill. Mice were group housed under a 12 h light/dark cycle with 
free access to food and water. Unless otherwise specifi ed, mice 
were fed a purifi ed low-fat diet (Research Diets, DB12451B). A 
multitissue knockout of ACSL1 was achieved by mating mice with 
loxP sequences fl anking exon 1 of the  Acsl1 gene to animals ex-
pressing a tamoxifen-inducible Cre driven by a ubiquitous pro-
moter enhancer ( 2 ). Between 6 and 8 weeks of age,  Acsl1 T  /   and 
littermate control  Acsl1 fl ox/fl ox (control) mice were injected intra-
peritoneally on four consecutive days with 20 mg/ml (75   g/g 
body weight) tamoxifen dissolved in corn oil. All studies were 
performed 20 weeks after tamoxifen was injected unless other-
wise specifi ed. Cardiac echocardiography was performed (blinded 
to mouse type) on conscious mice using a VisualSonics Vevo 770 
or Vevo 2100 ultrasound biomicroscopy system (VisualSonics, Inc.). 
A model 707B (30 MHz) or model MS-550D (22–55 MHz) scan 
head was used on the Vevo 770 and Vevo 2100, respectively, 
as previously described ( 14 ). Two-dimensional guided M-mode 
echocardiography was performed in the parasternal long-axis 
view at the level of the papillary muscle on loosely restrained con-
scious mice. Wall thickness was then determined by measure-
ments of epicardial to endocardial leading edges. For the diet 
study, group-housed mice were fed a high-linoleate saffl ower oil 
diet [Research Diets, D02062104, 45% kcal fat (75% linoleate)] 
for 4 weeks and were weighed weekly. 
 ACSL activity assay 
 ACSL specifi c activity was measured in heart membranes and 
cell homogenates ( 2 ). Briefl y, homogenized tissues were centri-
fuged at 100,000  g for 1 h at 4°C to isolate total membrane frac-
tions. Between 1 and 6 µg of protein was incubated with 50 µM 
[1- 14 C]fatty acid (unless otherwise indicated), 10 mM ATP, 250   M 
CoA, 5 mM dithiothreitol, and 8 mM MgCl 2 in 175 mM Tris 
(pH 7.4) at room temperature for 10 min. The enzyme reaction 
was stopped with 1 ml of Dole’s solution (heptane-isopropanol-1 
M H 2 SO 4 ; 80:20:1; v/v). Two milliliters of heptane and 0.5 ml of 
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0.1 Da increments over 4 s. Quantitation was performed using 
AB Sciex MultiQuant software and using the internal standards 
for each phospholipid analyzed. Quantifi ed data were corrected 
for isotope abundance. Fragmentation of endogenous lipids of 
 m/z 818.5, 842.6, 844.6, 846.5, 864.5, and 890.5 (PC); 742.5, 
738.5, 790.5, 762.5 (PE); 885.5 (PI); and 1448.0 (CL) was per-
formed as described above, except for the following details. In 
the MS/MS experiment, the parent ions listed above were se-
lected in quadrupole 1 and subjected to collision-induced de-
composition using N 2 gas, and quadrupole 2 was allowed to scan 
the product ions in the  m/z range from 150 to 900 ( m/z 818.5, 
842.6, 844.6, 846.5, 864.5, 890.5, 742.5, 738.5, 790.5, 762.5, and 
885.5) or 150 to 1,450 ( m/z 1448.0). After each of these specifi c 
phospholipid molecular species was identifi ed, the number of 
acyl carbons and double bonds present in the set of fragment 
molecule was confi rmed. From these data, the other phospholip-
ids were converted from mass-to-charge to number of acyl car-
bons and double bonds. 
 Generation of stable ACSL1-knockdown H9c2 cells 
 Acsl1 rat shRNA or  scrambled control shRNA constructs in 
pGFP-C-shLenti vector (Origene) were cotransfected with pHR-
CMV-  8.2 and pCMB-VSV-G vectors in HEK293T cells to gener-
ate lentivirus. H9c2 cells (rat cardiomyocytes; ATCC) were 
incubated with media containing lentivirus for  Acsl1 shRNA or 
 scrambled shRNA for 24 h. Cells were treated with 1 µM puromy-
cin for 7 days to select cells that contained the shRNA. Knock-
down of ACSL1 was confi rmed by mRNA, protein, and ACSL 
enzyme activity. 
 Cellular phospholipid incorporation 
 H9c2 cells were cultured to confl uence in 25 mM glucose 
DMEM with 10% FBS. Cells were differentiated for 4 days in 
5 mM glucose DMEM with 1% horse serum. For overexpression 
experiments, cells were infected with adenovirus containing ei-
ther  GFP or  Acsl1-FLAG (multiplicity of infection of 150) for 24 h. 
Cells were incubated with 0.5 µCi [1- 14 C]palmitate, [1- 14 C]oleate, 
or [1- 14 C]linoleate for 6 h and then washed twice with 1% BSA. 
HEK-293 cells were grown to 50% confl uence in 25 mM glucose 
DMEM with 10% FBS and then infected with adenovirus contain-
ing either  GFP or  Acsl1-FLAG (multiplicity of infection of 2.5) for 
24 h. Cells were then incubated with a mixture of 30 µM oleate, 
15 µM palmitate, and 5 µM linoleate plus 0.5 µCi of either [1- 14 C]
palmitate, [1- 14 C]oleate, or [1- 14 C]linoleate for an additional 
24 h. For oxidation measurements, 0.4 ml media was collected 
in a tube containing 20 µL 15% BSA and then incubated with 
100 µL 20% perchloric acid overnight at 4°C. The acidifi ed 
media was centrifuged at 20,000 rpm for 5 min, and radioactiv-
ity in the supernatant was counted to determine acid-soluble me-
tabolites (ASMs). 
 Microscopy 
 H9c2 cells grown on glass coverslips were incubated with 
200 nM MitoTracker CMXRos (Life Technologies) for 30 min, 
fi xed with 3.7% paraformaldehyde, and permeabilized with 0.2% 
Triton X-100. Cells were incubated with primary antibody [FLAG 
(Sigma) and/or Grp78 (Novus Biologicals)] for 2 h and then 
secondary antibody (Alexafl uor 488 or 568; Life Technologies) 
for 1 h. Cells were then incubated with DAPI (Life Technologies) 
for 5 min, mounted on glass slides with Prolong Gold (Life Tech-
nologies), and visualized with a Zeiss 710 confocal microscope. 
 Statistics 
 Data are presented as the mean ± SE for each group. Differ-
ences between genotypes were evaluated by Student’s  t -test. For 
XF24 Analyzer. Mitochondria (15 µg protein) were stimulated 
sequentially with 100 µM ADP, 1.26 µM oligomycin, 4 µM 
2-[[4-(trifl uoromethoxy)phenyl]hydrazinylidene]propanedini-
trile (FCCP), and 4 µm antimycin A (Sigma-Aldrich). 
 Phosphate quantifi cation 
 Lipids were extracted from approximately 15 mg of ventricu-
lar myocardium, and phospholipids were separated by TLC on 
LK5D silica gel 150 Å plates (Whatman) in chloroform:ethanol:
water:triethylamine (30:35:7:35; v/v) with authentic standards 
( 16 ). Phosphate was quantifi ed in the scraped silica regions for 
each phospholipid. The reaction was initiated by adding 30 µl 
10% Mg(NO 3 ) 2 in ethanol to each sample and heating over an 
open fl ame ( 17 ). After adding 300 µl 0.5 N HCl, samples were 
boiled for 15 min. Then, 700 µl of a solution of 1.43% ascorbic 
acid and 0.36% ammonium molybdate in 0.86 N sulfuric acid was 
added, and the mixture was incubated at 45°C for 20 min. The 
absorbance of samples and a standard curve of sodium phos-
phate were measured at 605 nm. 
 Sample preparation for MS 
 Samples of left ventricle were homogenized on ice using 
a Dounce homogenizer in 50 mM phosphate buffer (pH 7.2), 
0.1 M NaCl, 2 mM EDTA, 1 mM dithiothreitol, and protease in-
hibitors (Roche). Protein was determined by the bicinchoninic 
acid method (Pierce Biotechnology). Preparations of heart mito-
chondria (180 µg protein) or total left ventricle (300 µg protein) 
were diluted with 50 mM PBS to a total volume of 200 µl. An in-
ternal standard mixture was made in 100% methanol containing 
1-dodecanoyl-2-tridecanoyl- sn -glycero-3-phosphate (PA-12:0/13:0), 
1-dodecanoyl-2-tridecanoyl- sn -glycero-3-phosphocholine (PC-
12:0/13:0), 1-dodecanoyl-2-tridecanoyl- sn -glycero-3-phosphoeth-
anolamine (PE-12:0/13:0), 1-dodecanoyl-2-tridecanoyl- sn -glycero-
3-phosphoglycerol (PG-12:0/13:0), 1-dodecanoyl-2-tridecanoyl-
 sn -glycero-3-phosphoinositol (PI-12:0/13:0), 1-dodecanoyl-2-
tridecanoyl- sn -glycero-3-phosphoserine (PS-12:0/13:0), and 1 ′ -
[1,2-di-(9 Z -tetradecenoyl)- sn -glycero-3-phospho], 3 ′ -[1-(9 Z -tetra-
decenoyl), 2-(10 Z -pentadecenoyl)- sn -glycero-3-phospho] sn -glycero 
[CL- (14:1) x3/15:1]. Then 750 µl of methanol:chloroform (2:1; 
v/v) and an internal standard mixture (for mitochondrial prepa-
rations and left ventricles on low-fat diet, 50 ng of each phospho-
lipid class and 100 ng of CL; for left ventricles on saffl ower oil 
diet, 25 ng of each phospholipid class and 100 ng of CL) was 
added, and products were extracted ( 18 ). The samples were 
dried under a stream of nitrogen and were then resuspended in 
100 µl of 75% solvent A (isopropanol:hexanes; 4:3; v/v) and 25% 
solvent B (isopropanol:hexanes:water, 4:3:0.7 [v/v], containing 
5 mM C 2 H 3 O 2 NH 4 ). Samples were analyzed by LC/MS/MS as de-
scribed below. 
 LC/MS 
 For normal phase separation, samples were injected onto an 
Ascentis-Si HPLC column (150 × 2.1 mm, 5 µm; Supelco) at a 
fl ow rate of 0.2 ml/min with 25% solvent B and 75% solvent A. 
Solvent B was maintained at 25% for 5 min, increased to 60% 
over 10 min, and then increased to 95% over 5 min. The system 
was held at 95% Solvent B for 20 min before re-equilibration at 
25% for 14 min. Phospholipids were measured using an API3200 
triple quadrupole mass spectrometer (AB Sciex). Positive ion 
mode was used to detect phosphatidylcholine (PC) and phospha-
tidylethanolamine (PE) lipids with quadrupole 1 scanning a  m/z 
range from 250 to 1,100 in 0.1 Da increments over 2 s. Negative 
ion mode was used to detect CL, phosphatidic acid, phosphati-
dylinositol (PI), phosphatidylglycerol, and phosphatidylserine 
with quadrupole 1 scanning an  m/z range from 150 to 1600 in 
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( Fig. 2D ) or pyruvate and malate ( Fig. 2E ) with increasing 
concentrations of ADP or succinate. Basal O 2 consump-
tion rate was normal in  Acsl1 T  /   mitochondria, but, com-
pared with controls, the mitochondrial response to ADP 
stimulation was 56% lower. In addition to impaired ADP-
stimulated oxygen consumption,  Acsl1 T  /   mitochondria 
produced less ATP for each O 2 molecule consumed, in-
dicative of ineffi cient energy production ( Fig. 2F ). Although 
many models of mitochondrial dysfunction produce in-
creased amounts of H 2 O 2 ,  Acsl1 
T  /   mitochondria did 
not, possibly due to their lower metabolic rate ( Fig. 2G ). 
Isolated  Acsl1 T  /   mitochondria took up less calcium 
than controls before reaching the permeability transition 
( Fig. 2H ), suggesting that  Acsl1 T  /   mitochondria may be 
more susceptible to stress and apoptosis. Calcium uptake 
into mitochondria increases oxygen consumption and 
NADH production, but once calcium uptake exceeds the 
permeability transition, mitochondria are more likely to 
become disrupted, release cytochrome c into the cytosol, 
and undergo apoptosis ( 20 ). Despite this severely impaired 
respiratory function,  Acsl1 T  /   mice do not develop heart 
failure under unstressed conditions ( 2 ) and have a normal 
lifespan (data not shown). 
 Loss of ACSL1 altered the acyl-chain composition of 
mitochondrial cardiolipin and phospholipids 
 Cardiolipin associates closely with complexes of the 
electron transport chain and is highly important for mito-
chondrial function ( 3, 4 ). Cardiac cardiolipin normally 
contains as much as 77% linoleate ( 8 ). Because ACSL1 has 
a distinct preference for linoleate, we questioned whether 
the loss of ACSL1 would affect the composition of cardio-
lipin and other phospholipids in cardiac mitochondria. 
The content of individual phospholipid species in cardiac 
ventricles did not differ between genotypes ( Fig. 3A ); how-
ever, in the knockout mice the average chain length and 
number of double bonds was lower ( Fig. 3B, C ). MS analy-
sis revealed that loss of ACSL1 caused large changes in the 
experiments with multiple treatments or diets, differences be-
tween groups were evaluated by two-way ANOVA with Tukey 
multiple-comparison post-tests. Differences between means with 
 P < 0.05 were considered statistically signifi cant. 
 RESULTS 
 ACSL1 was located on cardiac mitochondria and 
preferred to activate linoleate 
 Cardiac ACSL1 protein and ACSL specifi c activity were 
enriched in the mitochondrial fraction compared with 
whole tissue ( Fig. 1A , B ). Purifi ed recombinant ACSL1 
from rat liver shows a broad fatty acid substrate preference 
with varying chain lengths and degrees of unsaturation 
( 19 ). To determine the fatty acid substrate preference in 
mouse heart, long-chain acyl-CoA synthetase (ACSL) activ-
ity was assayed with different fatty acid substrates in total 
membrane preparations from control and  Acsl1 T  /   hearts. 
Control hearts exhibited the highest ACSL activity with 
linoleate (18:2) ( Fig. 1C ). This clear substrate preference 
was lost in  Acsl1 T  /   hearts, which lack more than 90% of 
total ACSL activity with all fatty acids ( Fig. 1D ), indicat-
ing that the preferential activation of linoleate was due 
to ACSL1 activity. 
 Loss of ACSL1 caused mitochondrial dysfunction 
 Acsl1 T  /   and littermate control mice were injected with 
tamoxifen at 6–8 weeks to produce ACSL1 defi ciency. Ten 
weeks after tamoxifen injection,  Acsl1 T  /   hearts are en-
larged but have normal systolic function ( 2 ). To determine 
whether function worsens with time, echocardiography 
was performed 20 weeks after initiating the ACSL1 knock-
out.  Acsl1 T  /   hearts remained hypertrophied, with no im-
pairment in contractile function ( Fig. 2 A–C ). To determine 
whether loss of ACSL1 caused mitochondrial dysfunction, 
O 2 consumption in saponin-permeabilized cardiac muscle 
fi bers was measured using palmitoyl-carnitine and malate 
 Fig. 1. ACSL1 is located on cardiac mitochondria 
and activates linoleate preferentially. A: ACSL1 pro-
tein from control heart homogenates and isolated 
mitochondria. B: ACSL activity of heart homogenates 
and mitochondria measured with 50 µM palmitate 
(n = 3). C: ACSL activity in total membrane fractions 
from control hearts measured with 2 µg protein and 
varying amounts of [ 14 C]labeled fatty acids (n = 3). D: 
ACSL activity in total membrane fractions from con-
trol and  Acsl1 T  /   mouse hearts measured with 2 µg 
protein and 50 µM of [ 14 C]labeled fatty acids (n = 3). 
*  P   0.05 between control and  Acsl1 T  /   . VDAC, 
voltage-dependent anion channel . 
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differences were seen in phosphatidylglycerol or phospha-
tidylserine (data not shown). In control mitochondria, the 
most abundant mitochondrial PI was 18:0, 20:4-PI. This 
species was 64% lower in the  Acsl1 T  /   hearts and was com-
pensated for by a higher content of multiple minor PI spe-
cies, so that the total content of PI was unchanged in the 
two genotypes. For PC, the major species in control hearts 
contained DHA (22:6) together with either palmitate 
(38:6-PC) or stearate (40:6-PC). Compared with controls, 
these species were 53% and 48% lower, respectively, in 
 Acsl1 T  /   hearts. PC species that contained DHA were re-
placed with oleate in the  Acsl1 T  /   mitochondria so that 
16:0-18:1-PC (34:1-PC) was 2-fold higher and 18:0-18:1-PC 
(36:1-PC) was 3-fold higher than in control hearts. The 
major PE species in control hearts also contained DHA 
and stearate (40:6-PE) and was approximately 30% lower 
in the  Acsl1 T  /   hearts. Impaired activation of   -linolenate 
due to loss of ACSL1 at the peroxisomal membrane may 
result in decreased uptake into peroxisomes where DHA 
synthesis occurs ( 21 ). The compositions of PC and PE in 
isolated mitochondria from control and  Acsl1 T  /   ventri-
cles were similar to those in total membranes (data not 
shown), supporting the idea that ACSL1 strongly infl u-
ences phospholipid synthesis in the endoplasmic reticu-
lum where these phospholipids are synthesized and 
remodeled ( 22 ). 
 Knockdown of  Acsl1 in H9c2 cardiomyocytes impaired 
the oxidation of fatty acid and its incorporation into 
complex lipids 
 To further investigate how the loss of ACSL1 affects 
phospholipid formation, we made a stable knockdown of 
 Acsl1 in H9c2 cells, a rat cardiomyocyte cell line. The 
acyl-chain composition of the major phospholipid species. 
As has been reported previously ( 8 ), the major cardiolipin 
(CL) species in control mouse hearts contained four lino-
leate acyl-chains (tetralinoleoyl-CL; 72:8-CL) ( Fig. 3D ). In 
the  Acsl1 T  /   mitochondria, however, this species was 83% 
lower, and compared with controls, the CL species con-
taining two linoleate and two arachidonate acyl chains 
(76:12-CL) was 80% lower.  Acsl1 T  /   heart mitochondria 
contained larger amounts of CL species esterifi ed with 
stearate (18:0) and oleate (18:1), indicating either that CL 
remodeling was impaired or that the availability of linole-
ate was limited. 
 To determine whether the loss of ACSL1 impaired lino-
leate incorporation into other phospholipids, several spe-
cies were fragmented to identify the acyl chains present. 
Linoleate-containing species of PC and PE (36:3-PC, 36:2-
PC, and 36:2-PE) were approximately 2- to 4-fold higher in 
 Acsl1 T  /   hearts than in controls. Excess linoleate in these 
species suggests that the absence of ACSL1, which is pri-
marily located on the mitochondrial outer membrane, al-
tered the incorporation of linoleoyl-CoA into PC and PE, 
which are synthesized and remodeled on the endoplasmic 
reticulum. Furthermore, the excess linoleate present in 
mitochondrial PC and PE was consistent with impaired 
transacylation from these donor phospholipids. Com-
pared with controls, the expression of the transacylase 
tafazzin was 31% lower in  Acsl1 T  /   hearts ( Fig. 3H ), sug-
gesting an explanation for both excess linoleate in PC 
and PE and the diminished tetralinoleoyl-CL, although 
we did not observe the increase in MLCL that is a hallmark 
of tafazzin defi ciency. 
 Loss of ACSL1 altered other mitochondrial phosphati-
dylinositol (PI), PC, and PE species ( Fig. 3E–G ), but no 
 Fig. 2. Loss of ACSL1 caused mitochondrial dys-
function. A: Left ventricle (LV) mass normalized to 
body weight (n = 4). Ejection fraction (B) and frac-
tional shortening (C) as measured by echocardiogra-
phy on conscious mice (n = 4). Consumption of O 2 
was measured in saponin-permeabilized cardiac mus-
cle fi bers with either (D) palmitoyl-carnitine + malate 
(PC/M) or (E) pyruvate + malate (Pyr/Mal) ± ADP 
and succinate (succ). RCR, respiratory control ratio. 
F: ratio of ADP-stimulated O 2 consumption to basal 
(n = 4–6). G: Ratio of ATP produced for each O 2 mol-
ecule consumed (n = 4–5). E: Hydrogen peroxide 
(H 2 O 2 ) production (n = 6). H: Calcium uptake in iso-
lated cardiac mitochondria before the permeability 
transition (n = 3). *  P   0.05 between control and 
 Acsl1 T  /   . 
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rely minimally on fatty acid oxidation for energy. Thus, 
compared with heart, in which palmitate is more readily 
oxidized, cultured cells activate more palmitate destined 
for esterifi cation into phospholipids. Other than PC, in 
which 37% less oleate was incorporated, no differences in 
the incorporation of oleate into phospholipids were ob-
served between control and  Acsl1 knockdown cells. Thus, 
in cultured cardiomyocytes, as in liver ( 23 ), loss of ACSL1 
impaired the activation of fatty acids that were incorpo-
rated into TAG and phospholipids, with the largest effects 
found with palmitate and linoleate. 
 Overexpressed ACSL1 increased linoleate metabolism 
 To confi rm the dependence of CL remodeling on lino-
leate that had been activated by ACSL1, ACSL1 was over-
expressed in H9c2 cardiomyocytes ( Fig. 5A ), where it 
localized primarily to mitochondria ( Fig. 5B ). The  Ad-
Acsl1 infection increased ACSL specifi c activity 3.3-fold 
( Fig. 5C ). After a 6 h incubation with trace amounts of 
each of the [1- 14 C]fatty acids, the cells overexpressing 
ACSL1 increased linoleate oxidation by 28%; however, the 
oxidation of palmitate and oleate did not change ( Fig. 
5D ). ACSL1 overexpression increased palmitate and lino-
leate incorporation into total lipids by 17% and 26%, 
respectively ( Fig. 5E ). ACSL1 overexpression increased 
knockdown caused a 67% loss of  Acsl1 mRNA, a 55% re-
duction of ACSL1 protein, and a 26% decrease in total 
ACSL activity ( Fig. 4 A–C ). To avoid high concentrations 
of fatty acid, which drives triacylglycerol synthesis, cells 
were incubated with trace amounts of individual [1- 14 C]
fatty acids (palmitate, oleate, or linoleate) to measure 
their incorporation into phospholipids. As measured by 
ASMs in the media, the oxidation of these fatty acids was 
80% lower in the  Acsl1 knockdown cells than in controls 
( Fig. 4D ), consistent with the requirement for ACSL1 in 
channeling long-chain fatty acids into the pathway of   -
oxidation ( 2 ). Decreased ACSL1 also caused approxi-
mately 40% lower incorporation of fatty acids into total 
glycerolipids ( Fig. 4E ). 
 The ACSL1 knockdown in H9c2 cells greatly dimin-
ished incorporation of fatty acids into neutral lipids and 
PC ( Fig. 4F, H ). The incorporation of linoleate into CL 
was 32% lower in  Acsl1 knockdown cells ( Fig. 4G ), which is 
consistent with the low content of tetralinoleoyl-CL in the 
 Acsl1 T  /   hearts. Compared with control cells, the incor-
poration of palmitate into PC, PE, PS, and CL was lower by 
43, 34, 17, and 46%, respectively ( Fig. 4H ). Consistent 
with  Acsl1 T  /   hearts, knockdown of ACSL1 resulted in a 
57% loss of tafazzin mRNA (data not shown). In contrast 
to highly oxidative cardiomyocytes in vivo, cultured cells 
 Fig. 3. Loss of ACSL1 alters acyl-chain composition 
of mitochondrial phospholipids. A: Quantifi cation of 
phosphate in ventricular phospholipids separated by 
TLC (n = 5). B and C: Average acyl chain length (B) 
and double bonds in mitochondrial phospholipids 
(C) were calculated using the isotope corrected area 
ratio determined by LC/MS/MS (n = 5). D–F: LC/
MS/MS analysis of phospholipid species in isolated 
mitochondria (n = 5). Phospholipid species are 
shown as relative amounts normalized to an internal 
standard for each phospholipid. Species that were 
fragmented are indicated with arrows and identifi ed 
acyl chains. Other species were detected but were 
omitted from graph if the isotope corrected ratio was 
<2 and no difference between genotypes was found. 
G: Ventricular tafazzin gene expression (n = 4). *  P   
0.05 between control and  Acsl1 T  /   . 
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contrast to the association of low ACSL1 with diminished 
 tafazzin abundance, ACSL1 overexpression did not raise 
 tafazzin expression (data not shown). In heart and skeletal 
muscle, which both contain high proportions of tetralino-
leoyl-CL ( 2, 23 ), the predominance of the ACSL1 isoform 
may underlie the enrichment in tetralinoleoyl-CL. 
linoleate incorporation into neutral lipid by 48%, cardio-
lipin by 28%, PC by 28%, and phosphatidylserine by 22% 
( Fig. 5F–H ). Palmitate incorporation was less infl uenced 
by overexpressed ACSL1; its incorporation into PC, PI, 
and phosphatidylserine increased 17–18%, similar to the 
17% increase seen in total lipid incorporation ( Fig. 5F ). In 
 Fig. 4. Knockdown of ACSL1 impairs fatty acid oxi-
dation and incorporation into lipids. H9c2 cells were 
infected with lentivirus to stably express shRNA for 
either  scrambled control ( Scr ) or  Acsl1 knockdown 
(KD). A: mRNA abundance of  Acsl isoforms ( Acsl6 
was not detected). B: ACSL1 protein. C: ACSL activity 
measured with 50 µM palmitate. D: Cells were incu-
bated with trace [1- 14 C]fatty acid (0.5 µCi) for 6 h. 
Fatty acid oxidation was measured as ASM, a measure 
of incomplete fatty acid oxidation, in the media. E: 
Radioactivity in total cellular lipid extract. F–H: Lip-
ids were separated by TLC, and radioactivity was 
quantifi ed (n = 3 independent experiments, each 
performed in triplicate). *  P   0.05 between  Scr and 
 Acsl1 KD. 
 Fig. 5. Overexpression of ACSL1 increases linole-
ate metabolism. H9c2 cells were infected with either 
 Ad-GFP or  Ad-Acsl1-FLAG . A: ACSL1 protein. B: Sub-
cellular localization of ACSL1-FLAG. C: ACSL activity 
measured using 50 µM [1- 14 C]palmitate. D: After a 
6 h incubation with trace amounts of [1- 14 C]fatty acid 
(0.5 µCi), fatty acid oxidation was measured in ASMs 
(incomplete fatty acid oxidation) in the media. E: Ra-
dioactivity in total lipid extract. F–H: Lipids were 
separated by TLC, and radioactivity in each species 
was quantifi ed (n = 3 independent experiments, each 
performed in triplicate). *  P   0.05 between  Ad-GFP 
and  Ad-ACSL1-FLAG . 
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ACSL1 specifi cally increased linoleate incorporation into 
CL, which is remodeled within mitochondria. Enhanced 
linoleate retention in CL indicates that the synthesis of 
linoleoyl-CoA is suffi cient for its preferential incorpora-
tion into CL, even in noncardiomyocytes. 
 Dietary linoleate enrichment normalized tetralinoleoyl-
CL content but did not improve mitochondrial function 
in  Acsl1 T  /   hearts 
 The relevance of CL acyl-chain composition to normal 
oxidative phosphorylation is controversial ( 25, 26 ). In or-
der to determine whether the impaired respiratory func-
tion of mitochondria from  Acsl1 T  /   hearts resulted from 
the presence of linoleate-defi cient mitochondrial CL, we 
fed control and  Acsl1 T  /   mice a high saffl ower oil diet, in 
which 75% of the fatty acids are linoleate. Saffl ower oil 
feeding normalizes CL species in spontaneous hyperten-
sive rats and improves their mitochondrial function ( 27 ). 
After 4 weeks, weights were lower for the  Acsl1 T  /   mice 
fed the saffl ower oil diet ( Acsl1 T  /   , 27 g vs. controls, 35 g). 
The 4 weeks of saffl ower oil feeding markedly increased 
the total amount of linoleate in CL in both control and 
 Acsl1 T  /   hearts, although the abnormal ratio between 
control and  Acsl1 T  /   CL persisted, perhaps because the 
low linoleate activation resulted in lower cardiac uptake of 
this fatty acid species. The diet increased the amount of 
the tetralinoleoyl-CL species in  Acsl1 T  /   hearts 4-fold, 
compared with the amount present when the mice ate a 
low-fat diet. Importantly, the saffl ower oil diet increased 
the tetralinoleoyl-CL content of  Acsl1 T  /   hearts to a level 
 ACSL1 overexpression increased linoleate incorporation 
into CL in HEK-293 cells 
 To determine whether the ability of ACSL1 to increase 
linoleate incorporation into CL was specifi c to cardiomyo-
cytes, we overexpressed ACSL1 in HEK-293 cells, which 
normally contain little tetralinoleoyl-CL ( 24 ). Twenty-four 
hours after the  Ad-Acsl1 infection, ACSL1 protein was pres-
ent, and total ACSL specifi c activity had increased 9-fold 
( Fig. 6A , B ). At this time, cells were incubated for an ad-
ditional 24 h with a mixture of fatty acids to mimic the 
percentages in a physiological mixture of monounsatu-
rated, saturated, and polyunsaturated fatty acids (30 µM 
oleate, 15 µM palmitate, and 5 µM linoleate plus the addi-
tion of 0.5 µCi of either [1- 14 C]labeled oleate, palmitate, 
or linoleate). ACSL1 overexpression increased palmitate 
incorporation into total lipids by 43%, oleate incorpora-
tion by 49%, and linoleate incorporation by 75% ( Fig. 
6C ). The  Ad-Acsl1 infection did not alter the esterifi cation 
of these fatty acids into neutral lipids ( Fig. 6D ), showing 
that the differences in total lipid incorporation were due 
to integration into phospholipids. ACSL1 overexpression 
resulted in 41% and 94% higher incorporation of palmi-
tate and linoleate, respectively, into CL, but no difference 
was observed in oleate incorporation ( Fig. 6E ). ACSL1 in-
creased the incorporation of each of the fatty acids into 
PC, PE, and PI/PS ( Fig. 6F ), phospholipids that are syn-
thesized at the endoplasmic reticulum. The high incorpo-
ration of labeled fatty acids into these phospholipids is 
likely due to increased fatty acid uptake and elevated 
acyl-CoA concentrations in the cytosol, but, importantly, 
 Fig. 6. ACSL1 overexpression increased linoleate 
incorporation into CL in HEK-293 cells. HEK-293 
cells were infected with either  Ad-GFP or  Ad-Acsl1-
FLAG . A: ACSL1 protein. B: ACSL specifi c activity 
measured with 50 µM [1- 14 C]palmitate. C–F: Cells 
were incubated with 30 µM oleate, 15 µM palmitate, 
and 5 µM linoleate with 0.5 µCi [1- 14 C]oleate, [1- 14 C]
palmitate, or [1- 14 C]linoleate for 24 h. C: Radioactiv-
ity in total lipid extract. D–F: Lipids were separated by 
TLC, and radioactivity was quantifi ed (n = 3 inde-
pendent experiments, each performed in triplicate). 
*  P   0.05 between  Ad-GFP and  Ad-ACSL1-FLAG . 
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 Fig. 7. High linoleate diet partially normalized CL 
acyl-chain profi le in  Acsl1 T  /   hearts but did not im-
prove mitochondrial respiratory function. For 16 
weeks after tamoxifen injections, male mice were fed 
a low-fat (10% fat) control diet. Mice were then either 
maintained on the low-fat diet or switched to a high 
saffl ower oil diet (Research Diets, D02062104, 45% 
kcal fat; 75% linoleate) for 4 additional weeks to in-
crease dietary linoleate. A: LC/MS/MS analysis of 
ventricular cardiolipin with low-fat and saffl ower oil 
diets (n = 5). B: Ventricular tafazzin gene expression 
in mice fed saffl ower oil (n = 5). C and D: Mitochon-
drial respiratory function was measured in isolated 
mitochondria using a Seahorse XF24 Analyzer, which 
sequentially injected ADP, oligomycin, FCCP, and 
antimycin A (n = 4–7). OCR, O 2 consumption rate. 
*  P   0.05 between genotypes within diet.  # P   0.05 
between diets within genotype. 
that was equal to the content in hearts from control mice 
fed the low-fat diet ( Fig. 7A ).  Tafazzin expression was not 
altered by diet, and the normalization of tetralinoleoyl-CL 
content was not due to increased  tafazzin expression, be-
cause the expression of this gene remained 25% lower in 
the saffl ower oil-fed  Acsl1 T  /   mice compared with con-
trols ( Fig. 7B ). To determine the effect of normalized te-
tralinoleoyl-CL content on mitochondrial respiration, we 
measured the function of the electron transport chain in 
isolated mitochondria. Basal O 2 consumption did not dif-
fer between groups ( Fig. 7C ). Similar to the data from 
permeabilized cardiac fi bers,  Acsl1 T  /   hearts contained 
functionally defective mitochondria, as shown by im-
paired responses to ADP and FCCP ( Fig. 7D ). In control 
mitochondria, saffl ower feeding increased respiration af-
ter oligomycin treatment but did not change the response 
to ADP or FCCP. However, despite the normalization of 
tetralinoleoyl-CL content, saffl ower oil feeding did not im-
prove the respiratory function of mitochondria from 
 Acsl1 T  /   hearts, and responses to both ADP and the mito-
chondrial uncoupler FCCP remained 30–44% lower than 
controls ( Fig. 7D ). 
 DISCUSSION 
 CL is synthesized and remodeled within the mito-
chondria, but its precursors, phosphatidic acid and CDP-
diacylglycerol, are formed primarily on the endoplasmic 
reticulum and are imported into the mitochondria where 
phosphatidylglycerol is synthesized ( 28 ). CL synthase then 
combines phosphatidylglycerol with the phosphatidyl 
group from a second molecule of CDP-diacylglycerol. Be-
cause CL synthase lacks a preference for phosphatidylglyc-
erol or CDP-diacylglycerol species that contain linoleate 
( 9, 29 ), the acyl-chains of the nascent CL are more highly 
saturated than those of mature cardiac CL. CL is remodeled 
by successive removal of acyl-chains by a phospholipase, 
followed by replacement of the acyl chain via tafazzin-
mediated transacylation from donor phospholipids or by 
an acyltransferase-mediated esterifi cation, which requires 
an acyl-CoA ( 10 ). 
 Although cardiac CL is highly remodeled after synthe-
sis, the functional signifi cance of the remodeling remains 
unknown. In  Saccharomyces cerevisiae lacking tafazzin, an ad-
ditional deletion of the CL-specifi c phospholipase, Cld1, 
prevents the accumulation of MLCL, inhibits CL remodel-
ing, and rescues the mitochondrial respiratory defect, 
strongly suggesting that the respiratory defect had been 
due to the accumulation of MLCL and/or the decrease in 
the total content of CL ( 25 ). In mammalian cells, two ad-
ditional enzymes, lysocardiolipin acyltransferase 1 (AL-
CAT1) and MLCL acyltransferase 1 (MLCL AT-1), can use 
acyl-CoAs to esterify MLCL ( 28 ). ALCAT1, however, is lo-
cated on the ER, which would prevent its interaction with 
most CL ( 30 ), but MLCL AT-1 is present in mitochondria 
( 11 ). Although overexpressing MLCL AT-1 in tafazzin-
defi cient lymphoblasts increases both linoleate incorpora-
tion into CL and total CL content ( 11 ), the importance of 
MLCL AT-1 for normal CL remodeling in heart cells re-
mains unclear. 
 With its preference for linoleate, ACSL1 appears to be 
critical in maintaining the abundance of the tetralinoleoyl-
CL species in the heart. This might occur in two ways: 
ACSL1-derived linoleoyl-CoA could be incorporated into 
donor phospholipids and then transacylated into CL, or 
the linoleoyl-CoA could be directly incorporated into 
MLCL by an acyltransferase. The mitochondria-located 
ACSL1 could increase the concentration of linoleoyl-CoA 
that is imported into mitochondria for   -oxidation or CL 
remodeling. Alternatively, because ACSL1 overexpression 
increases linoleate incorporation into PC, PE, and phos-
phatidylserine, its enhancement of CL species that contain 
linoleate could occur via transacylation of linoleate from 
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 In contrast to tafazzin-defi cient mice,  Acsl1 T  /   hearts do 
not contain a low total CL content or excess MLCL. Thus, 
the  Acsl1 T  /   model allowed us to study CL remodeling in 
the presence of a normal CL content as well as the impact 
of impaired tetralinoleoyl-CL formation on heart and mi-
tochondrial function. In  Acsl1 T  /   hearts, normalizing 
the amount of linoleate present in CL did not improve 
respiratory dysfunction. Similarly, in  S. cerevisiae , CL re-
modeling can be inhibited without impairing basal or 
ADP-stimulated mitochondrial O 2 consumption ( 25, 26 ). 
Thus, in both yeast and in  Acsl1 T  /   hearts, when total CL 
content is normal, mitochondrial function appears to be 
independent of the presence of a specifi c CL species. In 
contrast, hearts from tafazzin-defi cient mice and from 
people with Barth’s syndrome contain both an increased 
content of MLCL and a reduction in total CL ( 8, 41, 42 ). 
These CL changes are associated with a dilated cardiomy-
opathy, cardiac respiratory dysfunction, and heart failure 
( 43 ). Despite the presence of mitochondrial dysfunction, 
 Acsl1 T  /   mice do not develop heart failure, suggesting 
that when total CL abundance is normal, the absence of a 
high content of tetralinoleoyl-CL is not physiologically 
harmful. It will be important to determine whether the 
 Acsl1 T  /   hearts are more susceptible to impaired function 
when subjected to pressure overload. Conversely, normal-
izing tetralinoleoyl-CL in  Acsl1 T  /   hearts was not suffi -
cient to improve mitochondrial respiratory function. Our 
data, together with the published yeast studies ( 25, 26 ), 
suggest that the underlying diffi culty in Barth syndrome 
and tafazzin-defi cient mice is a defi ciency in CL content 
and/or the accumulation of MLCL.  
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